Alignment Independent 3D-QSAR Study of BACE1 Inhibitors as Anti-Alzheimer Drugs
Publish place: 20th Iranian Chemical Congress
Publish Year: 1397
نوع سند: مقاله کنفرانسی
زبان: English
View: 281
متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
IRANCC20_508
تاریخ نمایه سازی: 28 اردیبهشت 1398
Abstract:
β-secretase (beta-amyloid converting enzyme 1[BACE1]) is involved in the first and rate-limiting step of β-amyloid (Aβ) peptides production, which leads to the pathogenesis of Alzheimer s disease(AD).Therefore, is an appropriate target for developing novel anti-Alzheimer drugs. In order to understand the structural characteristics correlated with the potency of BACE1 inhibitors, a Molecular Interaction Fields (MIF) based alignment independent three-dimensional quantitative structure-activity relationship (3D-QSAR) study was conducted. The predicted values of pIC50 are in good agreement with the experimental results of biological activity, indicating that the 3D-QSAR model can be select for further studies. The resulted model PLS analysis indicated that the compound activities were in good agreement with experimentally observed values (R2=0.73, Q2LOO=0.57 and R2 Pred=0.842).
Authors
Milad Namroudi
Department of Chemistry, Faculty of Science, Golestan University, Gorgan, Iran
Shabnam Hooshmand
Department of Chemistry, Faculty of Science, Golestan University, Gorgan, Iran
Ghasem Bahlakeh
Department of Chemistry, Faculty of Engineering, Golestan University, Gorgan, Iran